![Sunitinib / Genentech / Renal cell carcinoma / Schistocyte / Food and Drug Administration / Thrombocytopenia / Microangiopathic hemolytic anemia / Medicine / Pharmacology / Bevacizumab Sunitinib / Genentech / Renal cell carcinoma / Schistocyte / Food and Drug Administration / Thrombocytopenia / Microangiopathic hemolytic anemia / Medicine / Pharmacology / Bevacizumab](https://www.pdfsearch.io/img/7c650db1fdf067e4507dca48914c8c8c.jpg)
| Open Document File Size: 46,22 KBShare Result on Facebook
City Rockville / / Company Pfizer Inc. / Development Chief Medical Officer Genentech Inc. / Genentech Inc. / / Event FDA Phase / / IndustryTerm Healthcare professionals / / MedicalCondition proteinuria / congestive heart failure / hypertension / headache / NSCLC / fatal / pulmonary hemorrhage / leukopenia / metastatic renal cell carcinoma / asthenia / abdominal pain / solid tumors / neutropenia / nausea / reversible posterior leukoencephalopathy syndrome / stomatitis / thrombocytopenia / ileus / hemoptysis / nephrotic syndrome / intra-abdominal abscess / severe hypertension / syncope / pain / vomiting / fatigue / deep vein thrombosis / diarrhea / infection / Microangiopathic Hemolytic Anemia / constipation / intra-abdominal thrombosis / anemia / dehydration / / MedicalTreatment elective surgery / chemotherapy / / Organization FDA / Avastin administration / / Person Hal Barron / / / Position Vice President / Fisher / / Product Avastin / Sutent / AvastinĀ® (bevacizumab) / / ProvinceOrState Maryland / / Technology chemotherapy / / URL www.accessdata.fda.gov/scripts/medwatch / /
SocialTag |